SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-014918
Filing Date
2023-06-08
Accepted
2023-06-08 17:23:17
Documents
1
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4055
  Complete submission text file 0000899243-23-014918.txt   5569
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIACELL, INC. 245 FIRST STREET CAMBRIDGE MA 02142
Business Address
Thistle Mary (Reporting) CIK: 0001317917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 231003006